ArticlePloS one2025
Towards point-of-care HIV testing: Terahertz PCF sensor integration and miniaturization.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Human Immunodeficiency Virus, or HIV, is a retrovirus which aims at CD4 cells in particular to destroy the body's natural defenses along with impair its capacity for fighting off illness plus ailments. In this circumstance we suggested a Photonic Crystal Fiber (PCF) sensor for detection of this lethal virus. Our intended sensor exhibits Max Relative Sensitivity (RS) 95.2% & 95% for x & y axis correspondingly when f = 3.0 THz. It also impresses us with minimal Confinement Loss (CL) of 1.06 × 10-7 & 2.04 × 10-7dB/m plus Effective Material Loss (EML) of 0.0078 & 0.0110 cm-1 in that order for x & y axis. Initial detection alongside prompt cures for HIV are made feasible by the remarkable efficacy of PCF biosensor observations in this regard. PCF gadgets offer rapid, non-invasive medical diagnosis, which simplifies the need for further evaluation & allows for an assessment of a condition's progression as it progresses. Precise assessment may be beneficial when investigating advancements that improve worldwide identification and therapeutic choices. It is possible that the rapid identification of these harmful microbes was made possible by the remarkable identifying ability provided by the new PCF. In conclusion, healthcare offers a plethora of opportunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.